Calif. High Court OKs Pay-For-Delay Challenges
The California Supreme Court ruled Thursday that so-called pay-for-delay pharmaceutical patent settlements can be challenged under state antitrust law, reviving drug buyers' claims that Bayer Corp. illegally paid generic manufacturers $400...To view the full article, register now.
Already a subscriber? Click here to view full article